Although less data are available for DDT, which has been discovered more recently, several preclinical and clinical data have concordantly shown high levels of MIF in a variety of human cancers [32,33,34], including pancreatic and gastric cancer, melanoma, hepatocarcinoma, glioma and cervical adenocarcinoma [30]. This evidence concerns the gene MIF and central nervous system cancer.